Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma

被引:20
作者
Ermiah, Eramah [1 ]
Eddfair, Mona [2 ]
Abdulrahman, Othman [2 ]
Elfagieh, Mohamed [3 ]
Jebriel, Abdalla [2 ]
Al-Sharif, Mona [4 ]
Assidi, Mourad [5 ,6 ]
Buhmeida, Abdelbaset [6 ]
机构
[1] National Cancer Institute, Med Res Unit, M20 S20, Algheran Qaryat Nosoor Aljaw St, Misurata 051, Libya
[2] Natl Canc Inst, Dept Med Oncol, Misurata 051, Libya
[3] Natl Canc Inst, Dept Surg, Misurata 051, Libya
[4] Univ Jeddah, Coll Sci, Dept Biol, Jeddah 21589, Saudi Arabia
[5] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Dept, Jeddah 21589, Saudi Arabia
[6] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia
关键词
pancreatic ductal adenocarcinoma; carcinoembryonic antigen; carbohydrate antigen 19-9; ELISA; expressions; prognosis; survival outcomes; CARCINOEMBRYONIC ANTIGEN CEA; TUMOR-MARKERS; INTERNATIONAL CONSENSUS; CANCER; CA-19-9; DIAGNOSIS; PREDICTION; SURVIVAL; SURGERY; IMPACT;
D O I
10.3892/mco.2022.2559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study investigated the associations of serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels with clinicopathological variables and survival outcomes in Libyan patients with pancreatic ductal adenocarcinoma (PDAC). The clinicopathological variables of 123 patients with PDAC registered at the National Cancer Institute in Misurata, Libya, between 2010 and 2018 were retrospectively analyzed. Blood samples from these patients were analyzed for serum CEA and CA19-9 levels before treatment by electrochemiluminescence immunoassay (double antibody sandwich ELISA) on a Roche cobas e 602 modules. The relationships between CA19-9 and CEA serum levels with clinicopathologic variables and survival outcomes were analyzed using the Kaplan-Meier method, log-rank test and Cox regression analyzes. Cut-off values for serum CEA and CA19-9 levels were 5 ng/ml and 400 U/ml, respectively. The median serum levels of all patients with PDAC for CEA and CA19-9 were 8 ng/ml (1.1-377 ng/ml) and 389 U/ml (1-10,050 U/ml), respectively. Tumors with higher serum CEA and CA19-9 levels were found in 63 and 48% of patients, respectively. Higher CEA and CA19-9 serum levels were significantly associated with more indicators of a malignant phenotype, including a surgically unresectable tumor, unevaluable lymph nodes, advanced stages and distant metastases. Regarding survival, patients with higher serum levels of the biomarkers CEA and CA19-9 had shorter overall survival rates (P<0.016 and (P<0.014, log-rank, respectively) and lower disease-free survival rates (P<0.002 and P<0.0001, log-rank, respectively). The present study demonstrated significant clinical and prognostic value of serum levels of biomarkers CEA and CA19-9 for Libyan patients with PDAC. Moreover, patients with PDAC with higher serum CEA and CA19-9 levels had more aggressive tumors, higher rates of disease recurrence and shorter overall survival rates and thus required more vigilant follow-up. Further multinational studies with larger PDAC cohorts are warranted to confirm these findings in terms of improved clinical decision making, more effective management and improved survival.
引用
收藏
页数:10
相关论文
共 51 条
[1]  
[Anonymous], 2021, NCCN Clinical Practice Guidelines in Oncology - Prostate Cancer
[2]  
[Anonymous], 2019, PANCR CANC TREATM PD
[3]   Autocrine loop between TGF-β1 and IL-1β through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells [J].
Aoki, H ;
Ohnishi, H ;
Hama, K ;
Ishijima, T ;
Satoh, Y ;
Hanatsuka, K ;
Ohashi, A ;
Wada, S ;
Miyata, T ;
Kita, H ;
Yamamoto, H ;
Osawa, H ;
Sato, K ;
Tamada, K ;
Yasuda, H ;
Mashima, H ;
Sugano, K .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (04) :C1100-C1108
[4]   Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer [J].
Asaoka, Tadafumi ;
Miyamoto, Atsushi ;
Maeda, Sakae ;
Tsujie, Masanori ;
Hama, Naoki ;
Yamamoto, Kazuyoshi ;
Miyake, Masakazu ;
Haraguchi, Naotsugu ;
Nishikawa, Kazuhiro ;
Hirao, Motohiro ;
Ikeda, Masataka ;
Sekimoto, Mitsugu ;
Nakamori, Shoji .
PANCREATOLOGY, 2016, 16 (03) :434-440
[5]   Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) [J].
Bockhorn, Maximilian ;
Uzunoglu, Faik G. ;
Adham, Mustapha ;
Imrie, Clem ;
Milicevic, Miroslav ;
Sandberg, Aken A. ;
Asbun, Horacio J. ;
Bassi, Claudio ;
Buechler, Markus ;
Charnley, Richard M. ;
Conlon, Kevin ;
Cruz, Laureano Fernandez ;
Dervenis, Christos ;
Fingerhutt, Abe ;
Friess, Helmut ;
Gouma, Dirk J. ;
Hartwig, Werner ;
Lillemoe, Keith D. ;
Montorsi, Marco ;
Neoptolemos, John P. ;
Shrikhande, Shailesh V. ;
Takaori, Kyoichi ;
Traverso, William ;
Vashist, Yogesh K. ;
Vollmer, Charles ;
Yeo, Charles J. ;
Izbicki, Jakob R. .
SURGERY, 2014, 155 (06) :977-988
[6]   Early Detection of Sporadic Pancreatic Cancer Summative Review [J].
Chari, Suresh T. ;
Kelly, Kimberly ;
Hollingsworth, Michael A. ;
Thayer, Sarah P. ;
Ahlquist, David A. ;
Andersen, Dana K. ;
Batra, Surinder K. ;
Brentnall, Teresa A. ;
Canto, Marcia ;
Cleeter, Deborah F. ;
Firpo, Matthew A. ;
Gambhir, Sanjiv Sam ;
Go, Vay Liang W. ;
Hines, O. Joe ;
Kenner, Barbara J. ;
Klimstra, David S. ;
Lerch, Markus M. ;
Levy, Michael J. ;
Maitra, Anirban ;
Mulvihill, Sean J. ;
Petersen, Gloria M. ;
Rhim, Andrew D. ;
Simeone, Diane M. ;
Srivastava, Sudhir ;
Tanaka, Masao ;
Vinik, Aaron I. ;
Wong, David .
PANCREAS, 2015, 44 (05) :693-712
[7]   Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - A retrospective tumor marker prognostic study [J].
Distler, Marius ;
Pilarsky, Eva ;
Kersting, Stephan ;
Gruetzmann, Robert .
INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (10) :1067-1072
[8]   Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging [J].
Eberlin, Livia S. ;
Margulis, Katherine ;
Planell-Mendez, Ivette ;
Zare, Richard N. ;
Tibshirani, Robert ;
Longacre, Teri A. ;
Jalali, Moe ;
Norton, Jeffrey A. ;
Poultsides, George A. .
PLOS MEDICINE, 2016, 13 (08)
[9]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[10]   Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians [J].
Giannis, Dimitrios ;
Moris, Dimitrios ;
Barbas, Andrew S. .
CANCERS, 2021, 13 (05) :1-17